-
Lyniate selected to connect Epic Electronic Patient Record in Health System in Northern Ireland
Boston, MA – August 23, 2022 – Lyniate, a global leader in healthcare data interoperability, has been selected by the Department of Health in Northern Ireland to provide data integration technologies for its encompass programme—a national digital transformation initiative designed to improve patient outcomes by better supporting health and care professionals.
Encompass, which includes the rollout of Epic to supply integrated electronic health records across Health and Social Care Northern Ireland (HSCNI), aims to create a single digital record for every citizen, with the goal of modernising health and social care in the country. The Department of Health selected Lyniate Rhapsody to integrate multiple health and social care systems containing the electronic records of thousands of patients and service users across Northern Ireland. Rhapsody will go live in 2023 as part of the Epic rollout.
The encompass programme will give patients and service users the ability to view and update their own health information. It will also make it easier for health and social care staff to view important information about their patients and service users across every episode of care.
Lyniate offers flexible, healthcare-focused data integration solutions and support services. Lyniate Rhapsody, which is used in 79 NHS Trusts, provides seamless integration with disparate systems across healthcare organisations, such as the electronic patient record, laboratory information system, and diagnostic imaging.
“Although Rhapsody works in the background, it ultimately helps improve frontline services for clinicians and patients,” said Dan West, Department of Health Chief Digital Information Officer. “While continued efforts have seen staffing numbers across the HSC increase, demand for services continues to outpace that expansion. Interoperability across our information and systems along with the roll-out of the new clinical platform unlocks the potential that exists for digital to play an important role in closing the capacity gap. Having Rhapsody as part of our IT infrastructure will help Northern Ireland on our path to becoming the first UK country with a single, connected electronic patient record. The solution will also help future-proof our IT environment so we can be more cost and time effective for care professionals and service users, enabling us to focus on delivering the safest and highest quality of care to the people of Northern Ireland.”
Erkan Akyuz, chief executive officer at Lyniate, added “We are 100% dedicated to solving healthcare problems and are honoured that HSCNI chose Rhapsody to improve the accessibility of, and trust in, health data as the country accelerates digital healthcare transformation. With Rhapsody, HSCNI can ensure the right data is in the hands of the right people at the right time.”
Lauren Usrey
Content Program Manager
C: (817) 266-3500
[email protected]Posted 8.31.2022 -
Lyniate Releases Latest Version of EMPI Solution to Manage Person Data
Enhanced offering will help care delivery organizations address data discrepancies that impact care
Boston, MA – August 11, 2022 – Lyniate, a global leader in healthcare data interoperability, has released the latest version of its Enterprise Master Person Index (EMPI) solution with numerous refinements. Lyniate EMPI by NextGate® version 11.2 features the industry’s most advanced offering to ensure patient data accuracy, using a powerful set of proprietary tools to identify and resolve identity data inconsistencies that referential data alone is unable to address.
As the industry continues to shift toward a more consumer-centric approach to care, healthcare delivery organizations and healthcare technology solution providers need accurate person data to maintain patients’ trust and understanding. Lyniate EMPI by NextGate features active management of identity data, delivering the highest degree of accuracy and garnering confidence through better patient connections. As organizations grow to deliver care across a variety of settings, the latest version of the Lyniate EMPI solution will help ensure continued access to current, accurate patient information to enable safe, quality care.
“We continue to invest in identity management as it is vital to the future of interoperability,” said Scott Galbari, president and coo of Lyniate. “We believe organizations need cutting-edge tools to manage identity data to provide the best possible experience – and best possible care – to their patient community, and that is why we have set ourselves apart from our competitors when it comes to identity data management. Lyniate is committed to meeting the unique needs of each organization and offering state-of-the-art options across the care continuum, which is why we are proud to feature this robust offering to improve data quality and data sharing.”
Features and benefits of Lyniate EMPI by NextGate version 11.2 include:
New workflow automation to ensure efficiency of the data stewardship process with automatic quarantining of patient data issues flagged for manual resolution and automated assignment of these data issues to a designated data steward
Comprehensive presentation of person data across all sources to reduce potential for erroneous adjudication and provide complete transparency to data lineage
Redesigned data stewardship workspace, developed in partnership with customers, for management of the data resolution process to present historical and conflicting person data intuitively to empower sound data resolution decision-making
“After recently evaluating some of the leading EMPI products available today, it became clear that Lyniate offered the most robust and proven solution to help strengthen the quality of data we exchange on behalf of our partners,” said Tom Visotsky, chief commercial officer of MedAllies. “We provide connectivity services to more than 700 hospitals and 100,000 providers, and the Lyniate EMPI will be an important tool to help our partners leverage person data to drive their most important initiatives.”
This new EMPI product release comes on the heels of the recently announced merger agreement with CareCom to offer solutions for advanced healthcare terminology mapping and NLP conversion of unstructured data. Married with Best-in-KLAS integration®, this powerful combination will empower healthcare to formulate a more complete and trusted profile for every person, enabling better care, reducing clinician burden, and optimizing patient experiences. Both of these announcements further showcase Lyniate’s commitment to investing in interoperability to improve care.
Lauren Usrey
Content Program Manager
C: (817) 266-3500
[email protected]Posted 8.31.2022 -
MedAllies Selects Lyniate for Enhanced Identity Data Management Capabilities
Top connectivity services company will leverage Lyniate EMPI solution to strengthen the accuracy of the data it exchanges to better serve its clients and partners
Boston, MA – August 18, 2022 – Lyniate, a global leader in healthcare data interoperability, today announced MedAllies, a leading multimodality connectivity services company, has chosen Lyniate Enterprise Master Patient Index (EMPI) by NextGate to better serve its healthcare clients and partners. This integration will bolster MedAllies’ identity data management capabilities to increase the accuracy of the data it exchanges for the benefit of all.
As the healthcare industry continues to shift toward a more consumer-centric approach to interoperability, MedAllies maintains its commitment to providing connectivity services to thousands of healthcare providers and organizations across the country. The company turned to Lyniate for its proven identity management solutions and unparalleled approach to facilitating real-time data exchange.
“MedAllies realized the pressing need to invest in EMPI technology, and we are excited to partner and provide solutions that will strengthen the company’s data exchange services,” said Scott Galbari, president and COO of Lyniate. “MedAllies understands the need to ensure the data it helps customers exchange is accurate so as not to negatively impact care, and recognizes that more accurate data can better support MedAllies’ own strategic initiatives. We applaud MedAllies for prioritizing this investment and having the vision to bring this crucial capability to its customers.”
Lyniate EMPI has the flexibility to support on-premises and cloud deployments with the ability to adapt and scale over time. It offers options for resolution of data issues using referential data as well as manual data remediation. Beyond its proven technology, Lyniate offers a world-class, hands-on approach to customer support and training to ensure its clients maximize their investment in patient data accuracy.
“Our clients and partners have spoken clearly: They need identity data solutions to be confident in the accuracy of the data that powers their businesses,” said Tom Visotsky, chief commercial officer at MedAllies. “After a great deal of due diligence, we came to the conclusion that Lyniate offers the most mature and robust EMPI solution on the market. We are excited to bring this powerful capability to meet our clients’ needs, fortify our care quality offering, and help our partners to thrive in a data-driven and consumer-focused healthcare environment.”
Lauren Usrey
Content Program Manager
C: (817) 266-3500
[email protected]Posted 8.31.2022 -
FDB Launches FDB Navigo™ — a Smarter, Holistic Approach to Optimize Clinical Guidance for Retail Pharmacy
New solution will streamline the retail pharmacist’s workflow and give them quality time to spend with patients.
SOUTH SAN FRANCISCO, August 25, 2022 – FDB (First Databank, Inc.), the leading provider of drug knowledge that helps healthcare professionals make precise decisions, announced today the launch of FDB Navigo™, a cloud-based solution that introduces a smarter, holistic approach to clinical guidance for medication safety risks. FDB Navigo provides retail pharmacists with targeted, consolidated and actionable clinical guidance at the most optimal time in their workflow.
FDB will debut FDB Navigo at the NACDS TSE conference August 27-29, 2022, in Boston, Mass.
FDB developed FDB Navigo over the past three years in collaboration with a major retail pharmacy chain. It streamlines the retail pharmacist’s workflow by changing the focus of medication safety alerts and the way these alerts are presented and processed. Specifically, FDB Navigo provides actionable guidance to the pharmacist based on the most important risks to the patient as reflected in the patient’s clinical record in the pharmacy’s system. Furthermore, FDB Navigo consolidates the appropriate information across all major clinical domains—including drug interactions, allergies, precautions and dosing information—to eliminate the current “siloed” approach in which retail pharmacists need to consider alerts within each clinical domain. The solution can also learn from previous pharmacist actions—for example, eliminating alerts at prescription refill if they were already addressed in previous fills.
FDB Navigo assists the retail pharmacist to determine the “next best step” for each patient, whether that is to fill the prescription, provide additional guidance to the patient, or follow up with the patient’s physician. To provide further support, FDB Navigo identifies therapeutic alternatives when available based on the patient’s risk and equips the pharmacist with a scripted narrative that can be used when counseling the patient or when discussing interventions with the physician. These innovations help standardize pharmacist actions across all pharmacies to better ensure patient safety, while also improving the experience for the pharmacist, provider and patient.
FDB Navigo helps to significantly reduce the number of alerts retail pharmacists receive in order to alleviate their cognitive burden. Unlike legacy clinical screening solutions, this new solution helps retail pharmacists, who are increasingly taking on expanded roles in patient care, to easily identify and respond to medication risks pertinent to individual patients to improve patient safety. Ultimately, FDB Navigo gives retail pharmacists more time and cognitive space to consult with patients and offer more primary care services.
“As retail pharmacists take on greater responsibilities beyond filling prescriptions and providing general advice for taking medications, demands on their time and energy have increased,” said FDB President Bob Katter. “FDB is pleased to offer a transformative clinical guidance solution that helps pharmacists meet these demands and practice at the top of their license in order to best serve the health and safety needs of their patients.”
Many retail pharmacies now offer a broader range of patient care services such as administering vaccines; testing for HIV, COVID-19 and other conditions; prescribing certain medications; conducting mental health screenings; educating patients about protective health measures; and delivering medication adherence and medication therapy management programs for patients with chronic conditions. Given this evolving role, 92% of patients view their pharmacist as a healthcare provider.
Even though retail pharmacists increasingly provide direct care for patients, a recent survey concluded that they are only able to spend 10% of their time counseling patients. Furthermore, the same survey reported that 75% of retail chain pharmacists and 53% of independent retail pharmacists feel they should spend more time devoted to patient counseling and medication therapy management.
FDB Navigo can help retail pharmacists free up time to perform these important services. Real-world pharmacy data collected while developing the FDB Navigo solution indicates that between 30% and 50% of alerts that pharmacists currently need to review can be eliminated. Once FDB Navigo is fully deployed, retail pharmacists can expect to see a larger decrease in alert volume.
Chirag Patel, PharmD, senior product manager for FDB said: “FDB Navigo leverages additional patient information such as prescription history, previous alert outcomes, and universal medication schedule, to provide patient-specific context for clinical guidance, helping to ensure medication safety. This product development approach, also reflected in other solutions within FDB’s PatientFirst™ suite, helps retail pharmacists make more precise, evidence-based decisions.”
To learn more about FDB Navigo, visit FDB at the NACDS TSE Conference, August 27 – 29 in Boston, booth #1817 or email [email protected].
About FDB
FDB (First Databank) creates and delivers the world’s most powerful drug knowledge that ignites, inspires, and illuminates critical medication decisions. We collaborate with our partners to help improve patient safety, operational efficiency, and health outcomes. Our drug databases drive healthcare information systems that serve the majority of hospitals, physician practices, pharmacies, payers, and all other areas of healthcare and are used by millions of clinicians, business associates, and patients every day. Please visit us at https://www.fdbhealth.com/, or follow us on Twitter, LinkedIn and YouTube.About Hearst Health
The mission of Hearst Health is to help guide the most important care moments by delivering vital information into the hands of everyone who touches a person’s health journey. Care guidance from Hearst Health reaches the majority of people in the U.S. The Hearst Health network includes FDB (First Databank), Zynx Health, MCG, Homecare Homebase and MHK. Hearst also holds a minority interest in the precision medicine and oncology analytics company M2Gen. Follow Hearst Health on Twitter @HearstHealth or LinkedIn @Hearst-Health.Contact:
Tara Stultz
Amendola Communications for FDB
M: 440-225-9595
[email protected]Posted 8.25.2022 -
Emarsys, an SAP Company, Partners with Clearwater to Ensure Practices Meet Healthcare Industry Cybersecurity and HIPAA Compliance Requirements
Leading Provider of Personalization Software Becomes One of the Latest Subscribers to Clearwater’s ClearAdvantage Program
INDIANAPOLIS, IN, AND NASHVILLE, TN (August 23, 2022) – Emarsys, an SAP (NYSE: SAP) company, and Clearwater, the leading provider of Enterprise Cyber Risk Management and HIPAA Compliance solutions for the healthcare industry, announced today that Emarsys has become one of the latest subscribers to ClearAdvantage®. Clearwater’s multi-year managed services program provides customers with the benefits of an integrated and efficiently executed, best-in-class cybersecurity and HIPAA compliance program at 25%-50% of cost of traditional approaches.
Recently named a leader for the fourth time in the 2022 Gartner® Magic Quadrant™ for Personalization Engines, the Emarsys customer engagement solution empowers marketers to deliver personalized experiences across multiple channels and drive business outcomes. As the company works to grow its customer base in the U.S. healthcare market, Emarsys recognizes the strategic importance of having a best-in-class cybersecurity and HIPAA compliance program.
“Healthcare is an especially important area for sensitive, articulate personalization, and an industry where discretion is entirely non-negotiable,” said Joanna Milliken, CEO, Emarsys. “Partnership with Clearwater is the latest step towards the highest security, privacy, and compliance standards possible, with Emarsys committed to exceeding expectations for all customers.”
By partnering with Clearwater, which was rated both the top Security Advisors & Consultants and top Compliance & Risk Management solution in Black Book Market Research’s latest survey of healthcare provider IT and security professionals, Emarsys is gaining access to the broad and deep expertise of Clearwater’s full consulting team, orchestrated by a dedicated program leader who will take responsibility for developing a strategic roadmap and tactical workplans that align with the company’s needs and objectives. Emarsys’ ClearAdvantage subscription also includes ongoing use of Clearwater’s IRM|Pro® software platform, which was purpose-built to help customers manage cyber risk and compliance with HIPAA Security, Privacy, and Breach Notification Rules.
The end result is a program built on recognized industry standards that addresses a range of key concerns from cybersecurity governance and incident response to OCR-Quality® Risk Analysis and Risk Management.
“We are proud to add yet another technology leader to our roster of ClearAdvantage subscribers,” says Clearwater CEO Steve Cagle. “Technology companies working in healthcare are recognizing the tremendous value of partnering with Clearwater to design, implement, and operate a program that is reasonable and appropriate for their organization, aligned with their strategic business objectives, and far less expensive than if they built it themselves or attempted to acquire the same capabilities through different point solution providers.”
About Emarsys
Emarsys, an SAP company, is the omnichannel customer engagement solution that empowers marketers to build, launch, and scale personalized, cross-channel campaigns that drives business outcomes. We partner with more than 1,500 companies from global enterprises to fast-moving mid-market brands across industries.Emarsys is purpose-built to give more power to marketers so they can:
- Accelerate time to value by quickly onboarding data and channels to deploy cross-channel campaigns
- Deliver real-time, 1:1 personalization that builds trusted, loyal and lasting customer relationships with every interaction
- Succeed with proven guidance to make smart, quick decisions with data-driven insights and analytics
- Produce measurable results that drive predictable and profitable growth throughout the customer lifecycle
To learn more, please visit www.emarsys.com.
About Clearwater
Clearwater is the leading provider of cybersecurity, risk management, and HIPAA compliance software, consulting, and managed services for the healthcare industry. Our solutions enable organizations to avoid preventable breaches, protect patients and their data, meet regulatory requirements, and optimize cybersecurity investments. More than 400 healthcare organizations, including 70 of the nation’s largest health systems and a large universe of physician groups and digital health companies, trust Clearwater to meet their cybersecurity and compliance needs. For more information about Clearwater, please visit https://clearwatercompliance.com.
###
Posted 8.23.2022 -
Parker Health Becomes Early EHR Participant in FDB Vela™ ePrescribing Network
Parker Health partners with FDB Vela to expand capabilities & improve prescribing experience for Parker Suite™ users.
(August, 18 2022) Parker Health, an innovative biotechnology company, announced today its partnership with FDB Vela™, a new, cloud-native electronic prescribing (ePrescribing) network that enables the seamless flow of critical medication prescription information, benefits verification, and clinical decision support between prescribers, payers, pharmacies, and other constituents.Parker Health is an early electronic health record (EHR) participant in the FDB Vela network. The Parker Suite™ Healthcare Management System™ is the first and only Fast Healthcare Interoperability Resources (FHIR)-compliant, full-stack, cloud-based solution that unifies patient-centric data, practitioner engagement, care delivery and outcomes data. The transformative system increases interoperability among patients, providers, payers, researchers, and health systems.
“We’re excited to work with the incredible team at FDB Vela to help achieve more patient-centric care and better health outcomes for patients by optimizing the workflows of prescribers using the Parker Suite and by expanding their access to actionable data,” said Vincent Lopez, Parker Health founder and CEO. “We’re committed to the evolution of healthcare and increasing its accessibility and affordability. We’re also committed to improving the experience of prescribers so they can spend less time looking at a screen and more time face-to-face with the patient. FDB Vela is just the right partner to advance that journey.”
Chief among the advantages FDB Vela brings to Parker Health is the opportunity to introduce new, innovative ePrescribing tools and capabilities faster to the market due to rapid onboarding and streamlined integration into the FDB Vela network. New user-focused tools for the Parker Suite can gain access to FDB Vela and its services within weeks via a series of advanced APIs built on highly scalable and secure Microsoft® Azure technology.
FDB Vela’s full API experience allows Parker Health to control how the Parker Suite Health Management System displays prescription information inside the web and mobile application for prescribers. It also enables Parker Health to automate aspects of prescribing, such as drug lookup and recommendations based on patient condition. This eases the burden on prescribers and staff.
“Forward-thinking EHR developers understand the value of connecting with a neutral and secure ePrescribing network that takes advantage of the latest technology to help optimize their solutions’ features and functionality while speeding time to market,” said Lathe Bigler, general manager of FDB Vela. “We look forward to supporting Parker Health’s existing solutions as well as facilitating the implementation of new ePrescribing tools in Parker Suite to enhance prescriber efficiency while helping patients achieve the best possible outcomes.”
The FDB Vela network will provide Parker Suite users with real-time medication eligibility and benefits information, including out-of-pocket spending estimates and will facilitate faster fulfillment of specialty drugs as more specialty pharmacies join the network.
Parker Health’s Parker Suite also integrates information from FDB MedKnowledge®, the most widely used drug database in the United States. Connecting with FDB Vela will make it possible for Parker Suite users to share this information, including a broad set of clinically meaningful and actionable patient and medication insights, at the time of prescribing to help improve consumer medication safety and therapeutic efficacy. According to Parker Health, directly integrating with the FDB drug database and with FDB Vela gives patients greater knowledge of their medications plus greater control over their prescriptions and prescription costs.
“Integrating into FDB Vela will benefit prescribers and patients,” said Christopher Parker, chief technology officer of Parker Health. “Using trusted information from FDB along with our artificial intelligence-powered clinical decision support capabilities, our system can recommend prescriptions to providers during the encounter based on entered conditions and curated clinical evidence, reducing decision time and increasing consulting time with the patient.”
Parker added, “Together, patient and prescriber can also review local pharmacy prices and alternative therapies within the Healthcare Management System or on an Apple or Android mobile device. FDB Vela truly opens a world of opportunities and innovation within ePrescribing for every network participant.”
Read the Parker Health press release here.
Learn more about FDB Vela here.
Posted 8.22.2022 -
Lumeon Wins Gold Stevie® Award in 2022 International Business Awards®
Care orchestration leader recognized as most valuable technical innovation for work with NYC Health + Hospitals in automating care coordination for COVID-19
BOSTON – August 17, 2022 – Lumeon, the care orchestration leader, received a Gold Stevie® Award today as the most valuable technical innovation in the 19th Annual International Business Awards®. Lumeon’s automated care orchestration platform integrates real-time data, applies clinical knowledge, and employs intelligent automation to orchestrate care based on the individual needs of each patient, alleviating the burden on clinicians and staff, who otherwise coordinate care manually. The Lumeon platform dramatically enhances clinician and staff productivity while enhancing care team efficiency and reducing operating costs.
Among the award judges’ comments:
- Quite inspiring technical innovation, supporting a great cause. I am impressed by the clarity and creativity of your innovation, the achievements supported with strong evidence. Brilliant!
- Great solution during challenging times, and demonstrating actual, quantitative results
- The nominee has contributed significantly to the fight against Covid-19. They were able to provide a scalable solution to mitigate the influx of patients in hospitals and help triage effectively
- Precisely the kind of solution needed at the height of the pandemic. I hope this model would be available also to other emerging countries where there is a spike of cases. Imagine the impact it could have to HC management and response
“Our care orchestration platform throws a lifeline to clinicians and care teams facing endless, time-consuming manual tasks and workflows, which inhibit them from delivering the most value to their patients,” said Greg Miller, chief growth officer of Lumeon. “We’re honored to receive the prestigious Stevie Award, which affirms our leadership in automated care coordination.”
To help health systems better manage the surge of incoming patients during COVID-19, Lumeon developed a remote home monitoring solution, designed for patients that presented at the ED with COVID symptoms and even tested positive for the virus, but whose oxygen saturation levels did not warrant hospital admission. Upon discharge from the ED, patients self-enrolled in the Lumeon-powered solution for New York City Health & Hospitals, which sent secure text messages to them every 12-24 hours to assess symptoms. Lumeon initially worked with NYC Health + Hospitals on the initiative and deployed the solution in only eight days.
Lumeon also powered a solution, integrated with the health system’s Epic EHR platform, designed to combat the 20% to 40% no-show and late cancellation rates experienced during the height of the pandemic. By supporting patient communication preferences in multiple languages and flagging cancellations in the EHR, the solution streamlined the care coordination process and alleviated care team manual tasks. It helped reduce the hospitals’ no-show rate by 29%, contributing to approximately $18.2 million in projected revenue gains.
The International Business Awards are the world’s premier business awards program. All individuals and organizations worldwide – public and private, for-profit, and non-profit, large, and small – are eligible to submit nominations. The 2022 IBAs received entries from organizations in 67 nations and territories.
Winners will be celebrated during a gala banquet October 15 at the InterContinental London Park Lane Hotel – the first live IBA awards ceremony since 2019. Details about The International Business Awards and the lists of Stevie Award winners are available at www.StevieAwards.com/IBA
About Lumeon
Lumeon believes that care better coordinated is care better delivered. Lumeon is a digital health company that provides a cloud-based care orchestration platform that automates the tasks, workflow, activities, and events that occur during the process of coordinating care. With real-time, bi-directional data/system integration and the dynamic application of clinical intelligence and automation, Lumeon ensures that each patient receives the right care at the right time – every time. By automating care coordination, care teams deliver care faster, more efficiently, effectively, and consistently across the continuum of care, while also empowering clinicians and staff to work at the tops of their licenses and spend time with patients that need it most.
About the Stevie Awards
Stevie Awards are conferred in eight programs: the Asia-Pacific Stevie Awards, the German Stevie Awards, the Middle East & North Africa Stevie Awards, The American Business Awards®, The International Business Awards®, the Stevie Awards for Women in Business, the Stevie Awards for Great Employers, and the Stevie Awards for Sales & Customer Service. Stevie Awards competitions receive more than 12,000 nominations each year from organizations in more than 70 nations. Honoring organizations of all types and sizes and the people behind them, the Stevies recognize outstanding performances in the workplace worldwide. Learn more about the Stevie Awards at www.StevieAwards.com.###
Media Contact
Philip Anast
Amendola (for Lumeon)
312-576-6990
[email protected]Posted 8.18.2022 -
Pivot Point Consulting Supports Live Deployment of OCHIN Epic Electronic Health Record System at Chicago’s Erie Family Health
First Instance of OCHIN Epic in Illinois
NASHVILLE, Tenn., July 19, 2022 /PRNewswire/ — Pivot Point Consulting, a Vaco Company, and recognized 2022 #2 Best in KLAS: Overall IT Services Firm, today announced the full deployment of OCHIN’s Epic Electronic Health Record (EHR) system at Erie Family Health Centers (Erie), a nonprofit with 13 locations dedicated to the integrated healthcare needs of underserved communities across Chicago. This is the first instance of OCHIN Epic in Illinois.
Erie has more than 730 staff members across seven primary care centers, four of which include integrated dental care, one teen center and five school-based health centers, two of which are also open to the surrounding community. Erie cared for more than 88,000 patients in 2021 – the highest number in its 65-year history – providing medical, dental and behavioral health to those it serves. Out of 45 community health centers in Illinois, Erie now ranks in the top 1% of community health centers nationally and #1 in Illinois for newborn delivery volume.
“We are thrilled to partner with Pivot Point and OCHIN to deploy the Epic platform across our community-based health centers,” said Amy Valukas, COO at Erie, who also served as a sponsor for the overall project. “Our aim is to drive efficiencies, get more out of our data and build upon the robust connection between our clinical providers and our patients. We were able to deploy OCHIN Epic seamlessly across our organization leveraging a super user program, effective training, as well as a provider personalization program to enhance patient-provider engagements.”
The OCHIN Epic EHR technology enables all of Erie’s community health centers to access, organize, store and share electronic medical records with four Epic hospital partners. Pivot Point Consulting brings expert project management, resourcing and strategy services to their OCHIN partnership and this EHR transformation initiative.
According to Rachel Marano, Founder and Managing Partner at Pivot Point, “We are tremendously proud to partner with OCHIN and its members nationwide to successfully plan and implement the OCHIN Epic EHR platform. We are continually gratified by this important work to help superior community health centers like Erie leverage crucial technology so they can continue to deliver high-quality care to the communities they serve.”
About Erie Family Health
With a mission motivated by the belief that healthcare is a human right, Erie provides high-quality, affordable care to support healthier people, families and communities. Its vision statement is “All people living their healthiest lives.” Erie serves patients in nearly 200 zip codes from North Lawndale on Chicago’s west side north to Waukegan, regardless of a patient’s insurance status, immigration status, primary language, or ability to pay. Erie trains over 300 providers and healthcare workers annually to support this goal of healthcare accessibility. To expand healthcare access, Erie has also deployed an effective telehealth program and last year more than 26 percent of its total patient visits were via telehealth, and successfully served patients in 83 languages.About Pivot Point Consulting
Pivot Point Consulting enables healthcare organizations to realize the most value from their technology and resources through EHR, ERP, Strategy, Virtual Care, Data & Analytics, Cybersecurity, Service Desk, Application Support and Revenue Cycle Management services. Our experts deliver consulting, managed services and talent solutions to providers, payers, life sciences and technology organizations. In 2022, the firm ranked as the #2 Best in KLAS: Overall IT Services Firm, by KLAS (after being 2020 #1 Best in KLAS Overall IT Services Firm) and also ranked #2 in Partial IT Outsourcing. For more information, visit us at pivotpointconsulting.com.Media Contact:
Mardi Larson
Amendola Communications (for Pivot Point Consulting)
[email protected]SOURCE Pivot Point Consulting
Posted 8.4.2022 -
athenahealth Implements DrFirst’s Digital Engagement Solution to Encourage Patients to Follow Prescribed Treatment Plans
Automated, secure text messages provide patients with prescription details, including pick-up instructions, educational material, and savings information
“We’re pleased to partner with athenahealth to give its network of approximately 145,000 providers access to the RxInform platform so they can help patients overcome the common hurdles that lead them to abandon their medications at the pharmacy.”
Patients abandon 20% to 30% of new prescriptions, whether due to high out-of-pocket costs, concerns about side effects, procrastination, or other factors. This lack of medication adherence can lead to increased total cost of patient care and undesirable health outcomes, such as disease progression, hospitalization, or even death.
Now, the athenahealth electronic health record (EHR) system that helps providers maximize clinical productivity and focus on delivering high-quality care to patients connects with RxInform, which automatically triggers a secure message to a patient’s mobile device when a clinician sends a prescription order to a pharmacy. From the message, patients may receive cost savings opportunities as available for a prescribed therapy and can view detailed information regarding their prescriptions, with a focus on behavioral and educational issues that have been proven to reduce prescription abandonment. The experience is seamless for the prescriber and helps them ensure the best outcomes for their patients.
“We are always looking for innovative ways to drive better results for our customers and their patients – especially as the industry shifts more toward value-based care,” said Paul Brient, chief product officer for athenahealth. “Every provider wants to minimize prescription abandonment rates because non-adherence to medication regimens negatively affects desired clinical outcomes. By adding RxInform to the latest release of athenaOne, we are immediately giving all our providers an automated function within their established prescribing workflows to support better patient outcomes.”
Since 2017, RxInform has received more than three million patient ratings, with 92% overall positive scores. These results indicate that patients welcome these messages, presenting new opportunities for providers to nurture patient relationships and build loyalty outside of the exam room.
“Primary care providers and specialists who care for high-risk patients need tools to help people take their medications as prescribed,” said G. Cameron Deemer, president of DrFirst. “We’re pleased to partner with athenahealth to give its network of approximately 145,000 providers access to the RxInform platform so they can help patients overcome the common hurdles that lead them to abandon their medications at the pharmacy.”
About athenahealth, Inc.
athenahealth creates innovative healthcare technology that connects clinicians, patients, payers, and partners in differentiated ways. Our electronic health records, revenue cycle management, and patient engagement tools allow anytime, anywhere access, driving better financial outcomes for our customers and enabling our provider customers to deliver better quality care. In everything we do, we’re inspired by our vision to create a thriving ecosystem that delivers accessible, high-quality, and sustainable healthcare for all. For more information, please visit www.athenahealth.com.About DrFirst
Since 2000, DrFirst has pioneered healthcare technology solutions and consulting services that securely connect people at touchpoints of care to improve patient outcomes. We create unconventional solutions that solve care collaboration, medication management, price transparency, and adherence challenges faced in healthcare. We unite the Healthiverse—the interconnected healthcare universe—by providing our clients with real-time access to the information they need, exactly when and how they need it, so patients get the best care possible. DrFirst solutions are used by nearly 325,000 healthcare professionals, including 220,000 prescribers, 70,000 pharmacies, 290 HIS/EHRs, and 1,500 hospitals in the U.S. and Canada. To learn more, visit www.DrFirst.com and follow @DrFirst.Contacts
MEDIA:
athenahealth
Jean Borgman
[email protected]DrFirst
Katlyn Nesvold, Amendola Communications for DrFirst
715-559-0046
[email protected]Posted 8.4.2022 -
Clearwater Helps Hospitals and Health Systems Scale Cyber Risk Management and Compliance through Managed Services Program, ClearConfidence™
Program Solves Staffing Challenge By Combining a Dedicated Team of Experts with Purpose-Built Software Tools to Identify, Prioritize, and Manage Cyber Risk Across the Enterprise on a Continuing Basis
Clearwater, the leading provider of Enterprise Cyber Risk Management and HIPAA Compliance solutions for the healthcare industry, announced today the launch of its ClearConfidence program, a cyber risk managed services solution for hospitals and health systems. The new managed services program helps hospitals and health systems develop stronger security postures and more efficiently meet compliance requirements through ongoing risk analysis, risk management and compliance assessments, ensuring they are working with current data as systems change or new ones are added to an organization’s digital ecosystem.
Hospitals and health systems were already grappling with staffing shortages prior to COVID-19, which then exacerbated the problem. In cybersecurity alone, it’s estimated that 62% of teams are understaffed and face challenges in retention alongside hiring. This poses an incredible threat to healthcare as breaches and cyberattacks can have far-reaching consequences for organizations and even patient safety.
Clearwater’s ClearConfidence managed services program is aligned to the NIST Cybersecurity Framework, an industry best practice, and helps healthcare organizations gain an edge in identifying and responding to cyber risks even while faced with deficiencies in resources and expertise. The tech-enabled program features leadership and program management from healthcare cybersecurity experts, in all aspects of cyber risk management including, framing, analysis, response, and monitoring.
“Healthcare continues to face incredible staffing challenges, including non-clinical positions, like cybersecurity and privacy,” said Clearwater CEO, Steve Cagle. “Cyber criminals are seizing the opportunity to exploit these staffing challenges. Hospitals and health systems need to assess and respond to risk on an ongoing basis, because their environment is constantly changing. Healthcare providers must remain diligent in performing ongoing risk management as they add new software applications and devices. With ClearConfidence, we’re stepping in to fill the gaps and help customers answer the call for better protection against cyberattacks and breaches with the expertise and software to assess risks, and subsequently ensure investments are optimized to minimize enterprise cyber risk.”
ClearConfidence includes ongoing consulting services, on-demand access to cybersecurity risk experts, and purpose-built IRM|Pro® software to help healthcare organizations keep up with rapidly evolving cyber threats and maintain HIPAA compliance. ClearConfidence also helps healthcare organizations meet Promoting Interoperability Risk Analysis Requirements, OCR’s Final Guidance for Performing Risk Analysis, and HIPAA requirements for risk response and risk management. Additionally, the program can include services to satisfy the HIPAA Security Rule’s non-technical and technical evaluation requirements.
Traditionally healthcare organizations have performed high-level, point-in-time risk assessments; however, this approach can be outdated and insufficient for hospitals and health systems that have rapidly changing digital environments, and where vulnerabilities and risks are changing constantly. Additionally, the traditional approach puts stress and strain on already overburdened and limited cybersecurity and IT resources.
Clearwater’s ClearConfidence program addresses these challenges through a combination of people, processes and technology, that are engaged on an ongoing basis. As a result, the risk analysis provides more meaningful, actionable and current cybersecurity risk data, and risk mitigation plans are actively managed. Security leaders are confident that they know—and are appropriately responding to—key risks and they can get more accomplished with less of a burden on their internal resources.
“The ClearConfidence program from Clearwater has helped us create a continuous and ongoing approach to enterprise cyber risk management,” said Jackie Mattingly, CISO for Owensboro Health and a Clearwater customer. “It’s helped us establish organizational buy-in for our policies and standards and eliminated the panic and hustle to meet an annual risk analysis deadline. At the end of the day, it means we operate out of a different level of confidence that our systems and data are secured and protected.”
To learn more visit www.clearwatercompliance.com/ClearConfidence
About Clearwater
Clearwater is the leading provider of cybersecurity, risk management, and HIPAA compliance software, consulting, and managed services for the healthcare industry. Our solutions enable organizations to avoid preventable breaches, protect patients and their data, meet regulatory requirements, and optimize cybersecurity investments. More than 400 healthcare organizations, including 70 of the nation’s largest health systems and a large universe of physician groups and digital health companies, trust Clearwater to meet their cybersecurity and compliance needs. For more information about Clearwater, please visit www.clearwatercompliance.com.
Posted 8.3.2022 -
Clearwater Adds 24/7 Managed Detection and Response Services and HITRUST, CMMC and PCI Certification Services Through Acquisition of TECH LOCK
Strategic Move Strengthens Clearwater’s Position as Healthcare’s Leading Cybersecurity and Compliance Solutions Provider with Additional Managed Security Services and Compliance Services
NASHVILLE, TN and TROY, MI (July 26, 2022) – Clearwater, the healthcare industry’s top-ranked Security Advisors and Consultants and Compliance and Risk Management Solution provider, announced today that it has completed the acquisition of TECH LOCK, a leading provider of security management, threat detection, incident response, and compliance services. TECH LOCK operated as a subsidiary of RevSpring, a market leader in patient engagement and payment solutions. Terms of the transaction were not disclosed.
Built to scale for organizations of all sizes, TECH LOCK’s Managed Detection and Response (MDR) service uses a proprietary security orchestration and response (SOAR) engine that pulls together in seconds threat insight and provides quick access to multiple signals for an immediate and effective security response. Security operations center (SOC) analysts actively watch and hunt every event and threat signal. They have extended detection and response with immediate contextual data to neutralize threats based on severity and risk.
As healthcare organizations grapple with a rapidly evolving threat landscape, TECH LOCK’s proven security services that bundle 24/7 SOC, MDR services, along with other foundational security options, will provide Clearwater’s customers with valuable capabilities, delivered directly by Clearwater. These capabilities include preventing ransomware threats in real-time and blocking events, even on compromised or infected devices if needed. Services from TECH LOCK leverage cloud delivery and infrastructure, removing heavy on-site requirements and allowing for the security of hybrid environments and everything from workstations and servers, current and legacy operating systems, POS systems, and manufacturing operational technology.
In addition, TECH LOCK brings strength across several areas of compliance that complement Clearwater’s deep HIPAA expertise. TECH LOCK’s compliance services are led by industry-certified assessors able to provide HITRUST certifications, PCI audits, and CMMC assessments. They bring cost-effective value to clients with integrated and bundled assessments across multiple standards and offer compliance maintenance and validation to ensure that assessments run smoothly and that clients stay up-to-date with new requirements.
“This is a very exciting day for our company and for our customers as we’ve added great people, powerful technology, and key services to our solution portfolio that position Clearwater to deliver even greater value to the healthcare industry,” said Clearwater CEO Steve Cagle. “Clearwater now has capabilities to provide 24/7 expert detection and response services, giving clients enhanced cyber resiliency to protect data, reduce business interruption, and achieve better security outcomes. With these capabilities, Clearwater continues to be a partner that can address our customers’ growing list of cybersecurity and compliance needs. We will continue to innovate and deliver value-added solutions that enable our customers to succeed in building and executing strong cybersecurity, risk management, and compliance programs.”
TECH LOCK will operate as a new Clearwater subsidiary and continue serving customers in Healthcare, as well as Account Receivables Management, Financial Services, Hospitality, Insurance, and Manufacturing. TECH LOCK CEO Brian McManamon will serve as business unit leader, reporting to Mr. Cagle. TECH LOCK’S Chief Information Officer Steve Meyer and Chief Security Officer & Chief Technology Officer Steve Akers also will continue in senior roles within the new organization operating under the Clearwater umbrella.
“We are incredibly excited to join the Clearwater family,” McManamon said. “TECH LOCK and Clearwater share the goal of making accessible services that ease compliance challenges, enhance cybersecurity protection, and help address the growing problem of advanced threats. There is a tremendous opportunity to build on this foundation as one organization moving forward.”
ArentFox Schiff LLP served as legal counsel to Clearwater in the transaction. Waller Lansden Dortch & Davis, LLP served as legal counsel to RevSpring and TECH LOCK in the transaction.
About Clearwater
Clearwater is the leading provider of cybersecurity, risk management, and HIPAA compliance software, consulting, and managed services for the healthcare industry. Our solutions enable organizations to avoid preventable breaches, protect patients and their data, meet regulatory requirements, and optimize cybersecurity investments. More than 400 healthcare organizations, including 70 of the nation’s largest health systems and a large universe of physician groups and digital health companies, trust Clearwater to meet their cybersecurity and compliance needs. For more information about Clearwater, please visit www.clearwatercompliance.com.
About TECH LOCK
TECH LOCK enables organizations to respond to today’s modern cybersecurity and compliance challenges. Our focus is on delivering cohesive managed security and compliance services. We provide industry-leading technology, security operations, and threat response. Our clients receive premium threat detection, security management, and compliance maintenance with personalized support. TECH LOCK is uniquely qualified to perform PCI QSA/ASV, HITRUST, and CMMC assessments. To learn more, please visit www.techlockinc.com .
About RevSpring
RevSpring leads the market in patient engagement and payment solutions that inspire patients to participate in and pay for their healthcare. The company has built the industry’s most comprehensive and impactful suite of patient engagement, OmniChannel communications and payment solutions backed by behavior analysis, propensity-to-pay scoring, contextual messaging, and user experience best practices. Using proprietary data analytics to tailor the engagement from preservice to post-service, RevSpring improves the patient experience and outcomes for providers and their patients. To learn more, visit revspringinc.com/healthcare.###
Posted 8.1.2022